❤
Health
Analytics · Longevity · Performance
TREND ANALYSIS
Log at least 2 readings per marker and 7 days of wearable data to unlock trend analysis.
PROTOCOL · PHASE 2/8NOTION →
Cardiovascular
8-week cycle · Started Jun 25, 2026
Berberine1,500 mg/day
Nattokinase2,000 FU bid
Ezetimibe10 mg/day
TUDCA500 mg/day
TARGET OUTCOMES
ApoB
1.05
0.75–0.85
LDL-C
3.7
~2.3–2.7
Lp(a)
0.29
~0.18
LONGEVITY GOALSALL GOALS →
◎VO₂ Max>50ml/kg/minAge 42→∞Biological Age≤35yearsAge 45→♥ApoB<0.70g/LDec 2026→⚡Fasting Insulin<35pmol/LDec 2026→◎HRV (RMSSD)>60msOngoing→
Click any goal to view in Goals tracker
LIVE VITALSOURA OAUTH NOT CONFIGURED
◉HRV
53
ms28 June
♥RHR
—
☾Sleep
—
◎Readiness
—
↑VO₂ Max
—
○SpO₂
—